Also trades as: QIA.DE (XETRA) · $vol 29M

$44.75

+2.71 (+6.45%)

Weekly Expected Move ±5.6%

$40 $42 $45 $47 $50

NYSE · Healthcare · Medical - Diagnostics & Research · Tech Score Neutral · Power 52 · $9.2B mcap · 205M float · 1.29% daily turnover · Short 45% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$2.1B +5.7% ▲

5Y CAGR: +2.2%

Gross Profit

$1.3B +33.5% ▲

5Y CAGR: +0.9%

Operating Income

$520M +432.5% ▲

5Y CAGR: +6.1%

Net Income

$425M +408.3% ▲

5Y CAGR: +3.4%

EPS (Diluted)

$2.04 +436.8% ▲

5Y CAGR: +44.8%

EBITDA

$717M +94.8% ▲

5Y CAGR: +0.0%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$2.3B	$2.1B	$2.0B	$2.0B	$2.1B
YoY Growth	+20.4%	-4.9%	-8.2%	+0.7%	+5.7%
Cost of Revenue	$801M	$757M	$732M	$1.0B	$799M
Gross Profit	$1.5B	$1.4B	$1.2B	$967M	$1.3B
Gross Margin	64.4%	64.7%	62.8%	48.9%	61.8%
R&D Expenses	$190M	$190M	$199M	$193M	$188M
SG&A Expenses	$584M	$604M	$579M	$564M	$584M
Operating Expenses	$821M	$853M	$824M	$870M	$771M
Operating Income	$630M	$531M	$410M	$98M	$520M
Operating Margin	28.0%	24.8%	20.9%	4.9%	24.9%
Interest Expense	$54M	$58M	$53M	$44M	$33M
Income Before Tax	$626M	$513M	$430M	$121M	$490M
Tax Expense	$113M	$89M	$89M	$38M	$65M
Net Income	$513M	$423M	$341M	$84M	$425M
Net Margin	22.8%	19.8%	17.4%	4.2%	20.3%
EPS (Diluted)	$2.28	$1.90	$1.57	$0.38	$2.04
EBITDA	$895M	$779M	$689M	$368M	$717M
Shares Outstanding	225M	223M	217M	218M	208M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$502M	$521M	$483M	$534M	$533M	$540M	$492M	$535M
Cost of Revenue	$194M	$188M	$175M	$199M	$201M	$223M	$183M	$195M
Gross Profit	$308M	$333M	$309M	$334M	$331M	$317M	$310M	$340M
Gross Margin	61.4%	63.9%	63.8%	62.7%	62.2%	58.7%	62.9%	63.6%
R&D Expenses	$44M	$49M	$44M	$48M	$49M	$47M	$48M	$50M
SG&A Expenses	$141M	$142M	$138M	$149M	$143M	$154M	$142M	$147M
Operating Expenses	$196M	$214M	$193M	$212M	$202M	$163M	$193M	$208M
Operating Income	$112M	$119M	$115M	$122M	$129M	$154M	$117M	$132M
Operating Margin	22.3%	22.9%	23.9%	22.8%	24.3%	28.5%	23.7%	24.7%
Interest Expense	$11M	$11M	$7M	$8M	$8M	$10M	$11M	$10M
Income Before Tax	$116M	$126M	$120M	$127M	$135M	$109M	$86M	$132M
Tax Expense	$18M	$38M	$29M	$31M	$5M	$1M	$18M	$29M
Net Income	$98M	$88M	$91M	$96M	$130M	$108M	$68M	$103M
Net Margin	19.5%	16.9%	18.8%	18.0%	24.4%	20.0%	13.8%	19.3%
EPS (Diluted)	$0.44	$0.41	$0.41	$0.44	$0.60	$0.52	$0.33	$0.50
EBITDA	$178M	$183M	$171M	$184M	$277M	$169M	$148M	$142M
Shares Outstanding	224M	218M	220M	218M	218M	208M	209M	208M

QGEN NYSE